Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. Hunter C. A rare disease in two brothers. Proc R Soc Med. 1917;10(Sect Study Dis Child):104–16.
2. Wraith JE, Scarpa M, Beck M, Bodamer OA, De Meirleir L, Guffon N, et al. Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy. Eur J Pediatr. 2008;167(3):267–77. https://doi.org/10.1007/s00431-007-0635-4.
3. Sousa Martins R, Rocha S, Guimas A, Ribeiro R. Hunter Syndrome: the phenotype of a rare storage disease. Cureus. 2022;14(2):e21985. https://doi.org/10.7759/cureus.21985.
4. Demydchuk M, Hill CH, Zhou A, Bunkoczi G, Stein PE, Marchesan D, et al. Insights into Hunter syndrome from the structure of iduronate-2-sulfatase. Nat Commun. 2017;8:15786. https://doi.org/10.1038/ncomms15786.
5. Takeda. ELAPRASE® (Idursulfase). 2022. Available from https://www.elaprase.com/hcp/about.